#Orexo
LightNews LightNews
allermd.bsky.social
The #FDA accepted an investigational new drug application for the #epinephrine #intranasal #powder #OX640 for treating #anaphylaxis, according to a press release from #Orexo. www.healio.com/news/...
The #FDA accepted an investigational new drug application for the #epinephrine #intranasal #powder #OX640 for treating #anaphylaxis, according to a press release from #Orexo. https://www.healio.com/news/allergy-asthma/20260917/fda-accepts-investigational-new-drug-application-for-ox640-epinephrine-nasal-powder
September 19, 2026 at 11:00 AM
newsen.bsky.social
Orexo Reaches Non-Binding Settlement With US Department of Justice to Resolve Investigation#Sweden#Orexo#AmorphOX#Uppsala#Department_of_Justice
Orexo Reaches Non-Binding Settlement With US Department of Justice to Resolve Investigation
Orexo AB has reached a non-binding agreement with the US Department of Justice to settle an ongoing investigation, paving the way for future developments.
third-news.com
September 1, 2026 at 3:57 AM
newsen.bsky.social
Orexo and the DOJ: Navigating a Non-Binding Settlement Agreement#Sweden#Orexo#Uppsala#Justice_Department#Non-Prosecution
Orexo and the DOJ: Navigating a Non-Binding Settlement Agreement
Orexo has reached a non-binding agreement with the US Department of Justice to address a lengthy investigation. The settlement outlines potential payments and terms crucial for the company's future.
third-news.com
September 1, 2026 at 3:57 AM
l2plabs.bsky.social
Orexo reaches non-binding agreement in principle to settle investigation by US Department of Justice
UPPSALA, Sweden, Aug. 31, 2026 /PRNewswire/ -- Orexo AB (publ) (STO: ORX) (OTCQX: ORXOY) today announced that the company has reached a non-binding agreement in principle on the main elements of a settlement with the US Department of Justice (DOJ). Orexo is in the last stages of...
dlvr.it
September 1, 2026 at 3:42 AM
murgataer.bsky.social
Det blev som sagt en intensiv rapportvecka.

Generellt har mottagandena så här initialt varit bra.

Man bör ju egentligen utvärdera hur aktien gått inför rapporten osv, men det här är en liten ögonblicksbild.

Orexo räknas inte riktigt. De ska ta in pengar och fortsatte falla...
July 18, 2026 at 6:29 AM
murgataer.bsky.social
Lugnet före stormen nu...

Hela 12 av de 17 bolagen jag kollar mest på rapporterar nästa vecka:

AddLife
Arjo
Bactiguard
Biogaia
Bonesupport
Camurus
Cellavision
C-RAD
Getinge
Orexo
Vitrolife
Xvivo Perfusion

Tider för rapportsläpp och telefonkonferenser
👇
murgata.se/rapportperiod/
Rapportkalender för Q2 2026 | Murgata Equity Research
Här finns Murgatas länkar till rapportkommentarer med mera för rapportsäsongen för utvalda hälsovårdsbolag
murgata.se
July 8, 2026 at 4:30 PM
newsen.bsky.social
Orexo Achieves Significant Progress with OX390 in Groundbreaking In-Vivo Study#Sweden#Orexo#AmorphOX#Uppsala#OX390
Orexo Achieves Significant Progress with OX390 in Groundbreaking In-Vivo Study
Orexo's latest in-vivo study reveals promising results for OX390, a potential treatment for opioid overdoses linked to certain dangerous substances. This marks a pivotal step in addressing public health challenges.
third-news.com
May 19, 2026 at 3:00 PM
newsen.bsky.social
Orexo Announces Breakthrough in OX390 with Positive In-Vivo Study Results for Emergency Treatment#Sweden#Orexo#AmorphOX#Uppsala#OX390
Orexo Announces Breakthrough in OX390 with Positive In-Vivo Study Results for Emergency Treatment
Orexo has reported promising in-vivo study outcomes for OX390, an emergency treatment for xylazine and medetomidine overdoses, demonstrating rapid nasal absorption of atipamezole.
third-news.com
May 19, 2026 at 2:51 PM
murgataer.bsky.social
Fram med kalendern och boka in tider för rapportsläpp och telefonkonferenser inför Q1!

I rapporteringsordning:
Getinge
Arjo
Bonesupport
Bactiguard
Hansa
Vitrolife
Cellavision
Xvivo
Addlife
Orexo
Medicover
Raysearch
C-RAD
Biogaia
Camurus
Elekta
Sectra
👇
murgata.se/rapportperiod/
Rapportkalender för Q1 2026 | Murgata Equity Research
Här finns Murgatas länkar till rapportkommentarer med mera för rapportsäsongen för utvalda hälsovårdsbolag
murgata.se
April 12, 2026 at 4:12 PM
newsen.bsky.social
Exploring Orexo's R&D Day: Innovations and Strategic Directions Ahead#Sweden#Innovation#Stockholm#Orexo#AmorphOX
Exploring Orexo's R&D Day: Innovations and Strategic Directions Ahead
Join Orexo on March 24, 2026, for their R&D Day, where they will present strategic insights and evolving drug delivery technologies.
third-news.com
March 6, 2026 at 4:37 PM
newsen.bsky.social
Orexo R&D Day to Present New Strategies and Innovations on March 24, 2026#Sweden#Stockholm#Orexo#AmorphOX#R&D_Day
Orexo R&D Day to Present New Strategies and Innovations on March 24, 2026
Orexo AB proudly invites stakeholders to its R&D Day on March 24, 2026, in Stockholm, focusing on innovative strategies and future developments.
third-news.com
March 6, 2026 at 4:34 PM
l2plabs.bsky.social
Invitation & Agenda: Orexo R&D Day on March 24
UPPSALA, Sweden, March 6, 2026 /PRNewswire/ -- Orexo AB (Publ.), (STO: ORX) (OTCQX: ORXOY) today invites investors, analysts and media to attend the company's R&D Day on March 24, 2026. The event will take place at the Royal Swedish Academy of Engineering Sciences (IVA), Grev Turegatan...
dlvr.it
March 6, 2026 at 4:27 PM
l2plabs.bsky.social
Invitation & Agenda: Orexo R&D Day on March 24
UPPSALA, Sweden, March 6, 2026 /PRNewswire/ -- Orexo AB (Publ.), (STO: ORX) (OTCQX: ORXOY) today invites investors, analysts and media to attend the company's R&D Day on March 24, 2026. The event will take place at the Royal Swedish Academy of Engineering Sciences (IVA), Grev Turegatan...
dlvr.it
March 6, 2026 at 4:27 PM
newsen.bsky.social
Orexo Restructures Organizational Framework to Enhance New Product Development#Sweden#Orexo#AmorphOX#Uppsala#Zubsolv
Orexo Restructures Organizational Framework to Enhance New Product Development
Orexo AB has announced significant changes to its organizational structure and leadership team to sharpen its focus on product development and meet market demands.
third-news.com
March 6, 2026 at 3:39 PM
l2plabs.bsky.social
Orexo changes the organizational structure and management team to increase focus on development of new products
UPPSALA, Sweden, March 6, 2026 /PRNewswire/ -- Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), today announces changes to its organizational structure and management team. The changes are a result of the divestment of Zubsolv® in the US market and focus on advancing development programs and...
dlvr.it
March 6, 2026 at 3:38 PM
newsen.bsky.social
Orexo's Organizational Transformation Enhances New Product Development Focus#Sweden#Orexo#AmorphOX#Uppsala#Lisa_Moore
Orexo's Organizational Transformation Enhances New Product Development Focus
Swedish pharmaceutical company Orexo announces a major organizational change. This restructuring aims to boost its focus on new product development and enhancing existing technologies.
third-news.com
March 6, 2026 at 3:37 PM
l2plabs.bsky.social
Orexo changes the organizational structure and management team to increase focus on development of new products
UPPSALA, Sweden, March 6, 2026 /PRNewswire/ -- Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), today announces changes to its organizational structure and management team. The changes are a result of the divestment of Zubsolv® in the US market and focus on advancing development programs and...
dlvr.it
March 6, 2026 at 3:33 PM
murgataer.bsky.social
Förra veckans rapportreaktioner:
Getinge: -5.8%
Xvivo Perfusion: +3.6%
Arjo: -10.5%

Den här veckan: Ledigt mån & fre. 🙂

Tis: Vitrolife
Ons: AddLife
Tors: Bactiguard, Cellavision, Orexo

Rapportkalender
👇
murgata.se/rapportperiod/
February 2, 2026 at 6:19 AM
efntv.bsky.social
Börsglädjen håller i sig i USA samtidigt som ädelmetallerna fortsätter att slå rekord. Tisdagen, den sista handelsdagen innan jul, bjuder också på rejäla klappar till aktieägare i Novo Nordisk och lilla Orexo.

efn.se/play/borsfru...
Julglädje både på Wall Street och för Novo Nordisk
Julglädje både på Wall Street och för Novo Nordisk| Håll dig uppdaterad med aktuella ekonominyheter – gratis.
efn.se
December 23, 2025 at 9:37 AM
nyemissioner.bsky.social
Orexo säljer Zubsolv-rättigheterna i USA för lika mycket som hela börsvärdet, vilket även innebär att bolaget blir skuldfritt. Försäljningspriset motsvarar det förväntade kassaflödet fram till att patentet går ut. nyemissioner.se/nyheter/orex...
Orexo säljer Zubsolv i USA för lika mycket som hela börsvärdet
Orexo säljer Zubsolv-rättigheterna i USA för lika mycket som hela börsvärdet, vilket även innebär att bolaget blir skuldfritt. Försäljningspriset motsvarar det förväntade kassaflödet fram till att pat...
nyemissioner.se
December 22, 2025 at 10:23 PM
zackssmallcap.bsky.social
#ORX.ST #ORXOY #ORXOF Q&A with Robert DeLuca, President of Orexo US, Inc. | OTC Markets Nordic Investor Day 2025 Replay buff.ly/xd72zoW
October 31, 2025 at 12:54 PM
murgataer.bsky.social
Heaven and hell - dagens rapportreaktioner!

AddLife: +8.2%
Vitrolife: +2.1%
Xvivo Perfusion: +1.6%
Bactiguard: -5.5%
Bonesupport: -6.7%
Orexo: -20.1%

En del saker i kalendern har uppdaterats.

Imorgon släpps tre rapporter
👇
murgata.se/rapportperiod/
Rapportkalender för Q3 2025 | Murgata Equity Research
Här finns Murgatas länkar till rapportkommentarer med mera för rapportsäsongen för utvalda hälsovårdsbolag
murgata.se
October 23, 2025 at 5:33 PM
murgataer.bsky.social
Extremt hektisk torsdag eftersom "alla" ska på höstlov nästa vecka. 😉

Kalender med tider i bilden (länk längre upp):
AddLife
Bactiguard
Bonesupport
Orexo
Vitrolife
Xvivo
(plus C-RADs telefonkonferens)

Hittills har följande rapporterat (tis-ons):
Getinge, C-RAD, Arjo, Biogaia
October 22, 2025 at 8:49 PM